
Venture capital · Early to growth stage · Est. 2023
Capital Life Science
Life-science venture investor formed as a joint venture within the Mirae Asset group, backing drug-development companies in oncology, immunology and other therapeutic areas, with teams in Boston and San Francisco.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Capital Life Science right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Capital Life Science joined, from press and the firm’s own posts.
Every round Capital Life Science joined
Round sizes, Capital Life Science’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Capital Life Science backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Capital Life Science
Events where Capital Life Science’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Capital Life Science is based in Boston, United States. It also has offices in Menlo Park, San Francisco and New York City.
In 2023.
2 fund vehicles are on public registers (SEC adviser filings), including MIRAE ASSET CAPITAL LIFE SCIENCE INCEPTION I, LP and MIRAE ASSET BIOHEALTH INGENUITY FUND I, LP.
Stages: Seed, Series C+. Sectors: Biotech, Life sciences, AI. From the firm’s own website.
Invests mainly at Series A/B in therapeutics companies approaching the clinic, aiming for clinical proof of concept. Stays modality agnostic, favors validated modalities across five therapeutic areas, co-invests with top life science investors, seeks board seats, and uses Asian affiliates to source assets. From the firm’s own website.
Capital Life Science lists 2 portfolio companies on its website: Accent Therapeutics and Attovia.
Firms whose websites list some of the same companies include Atlas Venture and The Column Group.
Know before Capital Life Science’s next round is announced.
PRO tracks Capital Life Science’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.